Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?

by Zachary S. Wallace, Zachary S. Wallace, Zachary S. Wallace, Zachary S. Wallace, John H. Stone, John H. Stone, John H. Stone
Published 2019-12-01

Development of an IgG4-RD Responder Index

by Mollie N. Carruthers, John H. Stone, Vikram Deshpande, Arezou Khosroshahi
Published 2012-01-01

Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial

by Vibeke Strand, Sophie Dimonaco, Katie Tuckwell, Micki Klearman, Neil Collinson, John H. Stone
Published 2019-02-01

Development and Implementation of a Double-Blind Corticosteroid-Tapering Regimen for a Clinical Trial

by Neil Collinson, Katie Tuckwell, Frank Habeck, Monique Chapman, Micki Klearman, John H. Stone
Published 2015-01-01

IgG4-Related Disease

by John H. Stone, John K. C. Chan, Vikram Deshpande, Kazuichi Okazaki, Hisanori Umehara, Yoh Zen
Published 2013-01-01

Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis

by Zachary S. Wallace, Tyler Harkness, Kimberly G. Blumenthal, Hyon K. Choi, John H. Stone, Rochelle P. Walensky
Published 2020-05-01

IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor

by Arezou Khosroshahi, Rivka Ayalon, Laurence H. Beck, David J. Salant, Donald B. Bloch, John H. Stone
Published 2012-01-01

Design of the Tocilizumab in Giant Cell Arteritis Trial

by Sebastian H. Unizony, Bhaskar Dasgupta, Elena Fisheleva, Lucy Rowell, Georg Schett, Robert Spiera, Jochen Zwerina, Olivier Harari, John H. Stone
Published 2013-01-01

Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data

by Sara Gale, Huong Trinh, Katie Tuckwell, Neil Collinson, John H. Stone, Khaled Sarsour, Jinglan Pei, Jennie Best, Christine Birchwood, Shalini V. Mohan
Published 2019-02-01

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

by Sebastian Unizony, Timothy J. McCulley, Robert Spiera, Jinglan Pei, Paris N. Sidiropoulos, Jennie H. Best, Christine Birchwood, Andrey Pavlov, John H. Stone
Published 2021-01-01

Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis

by Damian R. Plichta, Juhi Somani, Matthieu Pichaud, Zachary S. Wallace, Ana D. Fernandes, Cory A. Perugino, Harri Lähdesmäki, John H. Stone, Hera Vlamakis, Daniel C. Chung, Dinesh Khanna, Shiv Pillai, Ramnik J. Xavier
Published 2021-02-01

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis

by Gwen E. Thompson, Gwen E. Thompson, Lynn A. Fussner, Amber M. Hummel, Darrell R. Schroeder, Francisco Silva, Melissa R. Snyder, Carol A. Langford, Peter A. Merkel, Peter A. Merkel, Paul A. Monach, Philip Seo, Robert F. Spiera, E. William St. Clair, John H. Stone, Ulrich Specks
Published 2020-09-01

Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis.

by Paul A Monach, Philipp Kümpers, Alexander Lukasz, Gunnar Tomasson, Ulrich Specks, John H Stone, David Cuthbertson, Jeffrey Krischer, Simon Carette, Linna Ding, Gary S Hoffman, David Iklé, Cees G M Kallenberg, Nader A Khalidi, Carol A Langford, Philip Seo, E William St Clair, Robert Spiera, Nadia Tchao, Steven R Ytterberg, Marion Haubitz, Peter A Merkel
Published 2012-01-01

IgG4‐related disease: Association with a rare gene variant expressed in cytotoxic T cells

by John H. Newman, Aaron Shaver, Jonathan H. Sheehan, Simon Mallal, John H. Stone, Shiv Pillai, Lisa Bastarache, Derek Riebau, Hugues Allard‐Chamard, William M. Stone, Cory Perugino, Mark Pilkinton, Scott A. Smith, Wyatt J. McDonnell, John A. Capra, Jens Meiler, Joy Cogan, Kelly Xing, Vinay S. Mahajan, Hamid Mattoo, Rizwan Hamid, John A. Phillips III, Undiagnosed Disease Network
Published 2019-06-01